Medication Assisted Addiction Treatment

Shyam A. Jha, MD

Shyam A. Jha, MD

Services Provided:

  1. Office Based Suboxone Treatment for Opioid Addiction
  2. Naltrexone / Campral Assisted Treatment for Alcohol Addiction
  3. Assistance to chronic pain patients in reducing their pain medications

Opioid Addiction: Suboxone Clinic

I offer an office based therapy to patients who need help with their narcotic/opioid dependence or addiction problem (also known as drug use disorder).

This applies to medications like Lortab, Percocet, Oxycodone, Oxycontin, Opana, Morphine, Methadone, Heroin, and similar drugs. I do not treat other forms of substance abuse, as there are no FDA approved medications for them.

Patients who have an addiction to narcotics/opioids find it very difficult to quit due to uncomfortable withdrawal symptoms. For such patients a medication (Brand names: Suboxone / Bunavail / Zubsolv) is available as a tablet or a film. This medication is taken by placing it under the tongue, from where it is rapidly absorbed, and is very effective in preventing symptoms of opioid withdrawal. This is a long acting drug … a single daily dose is sufficient for most patients.

This medication is available by prescription, and is dispensed through pharmacies. Patients are able to carry out this treatment in the privacy and comfort of their home. This medication is gradually reduced by the patient till there is no need for it.

This is a very gentle method, and can be carried out without any disruptions with work or school schedule. It does not require patients to be admitted to a residential facility.

The cost of treatment is much lower than what one spends on buying narcotic drugs illegally. The cost of outpatient treatment is much lower than inpatient/residential rehab.

I have certification to prescribe Suboxone. Currently more than 90 treatment slots are available in my program. I am not an addiction treatment specialist, or an addiction treatment facility. My practice only accepts self-pay patients, from Dallas-Fort Worth and surrounding areas.

My program does not accept insurance, does not require insurance, and does not require a referral.

It is a self contained program. Any services that are covered by your insurance, for example lab tests, can be obtained through your insurance providers.

If you are planning to go for residential rehab or an outpatient addiction recovery program then ask if they would provide or prescribe Suboxone.

Suboxone will completely stop your withdrawals and you will be able to pay attention to the program and absorb the teaching. If you attend the program while you are in withdrawal … then you will be miserable and will not benefit from the program.

If your rehab program does not provide Suboxone then it is best to avoid it … or enroll with a Suboxone provider before you go to the program.

Alcohol Addiction

Alcohol addiction is treated with Naltrexone, and, or, Acamprosate (Campral). These drugs are known to reduce craving for alcohol, and reduce withdrawal symptoms. Once cravings are controlled patients are better able to modify their behavior with the help of a counselor or behavior therapist.

Alcohol dependence or addiction treatment may also be available to you through your PCP; it does not require any special certification by the DEA.

This program does not require a referral.

When willpower is not enough … medication assisted treatment and counseling can help you with your recovery.

Pain Management: Reduction of pain medications

I do not offer chronic pain management anymore, but I do accept patients who wish to reduce their dependence on pain medications.

Patients must be motivated, and agree to reduce their opioid pain medications by at least 10% every month. When the patient has reached a stable point where further reduction is not possible, then they are encouraged to go back to their provider to continue their medications.

This program requires referral and reports from the PCP.

Additional information:



Self help resources

This page was last modified on: September 3, 2018